Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Israel Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20054
20064
20071
20081
20091
20102
20112
20121
20132
20142
20161
20171
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status2
Withdrawn2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Bristol-Myers Squibb5
Sheba Medical Center3
Hadassah Medical Organization2
Cancer Trials Ireland1
CytRx1
Deborah Rund1
Enliven Therapeutics1
European Society for Blood and Marrow Transplantation1
Gamida Cell -Teva Joint Venture Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive28
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Hematologic Neoplasms3
Leukemia3
Leukemia, Myeloid, Acute3
Philadelphia Chromosome3
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Chronic-Phase2
Lymphoma2

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.